Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

ConditionNeonatal Hypoxia

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

AgeUp to 1

SponsorSherief Abd-Elsalam

About this trial

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Eligibility criteria

Qualifiers

neonates with hypoxia.

Disqualifiers

hypoxic ischemic encephalopathy

Trial design

Treatments tested in this trial

Citicoline
Placebo

Treatment groups

40 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov